The Food and Drug Administration awarded a purchase order to Oready LLC for pharmaceutical manufacturing hands-on short courses valued at $316,000 on September 29, 2026, with ultimate completion by September 28, 2027. Oready is a woman-owned small disadvantaged business. Work is performed in Silver Spring, Maryland. The order covers five in-person, 8-hour training sessions for up to 40 personnel across unit operations including tableting, aseptic processing, granulation, lyophilization, fermentation, ultrafiltration/diafiltration, filling, and film-coating. Instruction spans raw material assessment through end-product testing, quality control, equipment operation and maintenance, and identification of quality-critical variables. Deliverables include training materials, pre-training packages, case studies, resource lists of FDA and ICH guidance, knowledge checks, and certificates of completion. Payment is due upon successful completion and Government acceptance of each session.